within Pharmacolibrary.Drugs.ATC.N;

model N02BB01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 2.7 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 900 / 1000000,
    adminCount     = 1,
    Vd             = 0.0006,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0025166666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Phenazone (also known as antipyrine) is a non-opioid analgesic and antipyretic formerly used for the relief of pain and fever. It is a pyrazolone derivative. Its use today is rare in many countries, having been largely replaced by safer and more effective agents, though it remains a classic model drug in pharmacokinetics studies due to well-established metabolic pathways.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers (mixed sex, typical age 20-40 years) after a single oral dose.</p><h4>References</h4><ol><li><p>Shimizu, H, et al., &amp; Ito, K (2023). Pharmacokinetics of Edaravone Oral Suspension in Patients With Amyotrophic Lateral Sclerosis. <i>Clinical therapeutics</i> 45(12) 1251–1258. DOI:<a href=&quot;https://doi.org/10.1016/j.clinthera.2023.09.025&quot;>10.1016/j.clinthera.2023.09.025</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37953075/&quot;>https://pubmed.ncbi.nlm.nih.gov/37953075</a></p></li><li><p>DeVane, CL, &amp; Nemeroff, CB (2001). Clinical pharmacokinetics of quetiapine: an atypical antipsychotic. <i>Clinical pharmacokinetics</i> 40(7) 509–522. DOI:<a href=&quot;https://doi.org/10.2165/00003088-200140070-00003&quot;>10.2165/00003088-200140070-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11510628/&quot;>https://pubmed.ncbi.nlm.nih.gov/11510628</a></p></li><li><p>Verbeeck, RK (2008). Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. <i>European journal of clinical pharmacology</i> 64(12) 1147–1161. DOI:<a href=&quot;https://doi.org/10.1007/s00228-008-0553-z&quot;>10.1007/s00228-008-0553-z</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18762933/&quot;>https://pubmed.ncbi.nlm.nih.gov/18762933</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N02BB01;
